DekaBank Deutsche Girozentrale
ACHN

DekaBank Deutsche Girozentrale’s Achillion Pharmaceuticals ACHN Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-54,300
Closed -$199K – 1268
2019
Q3 		$199K Sell
54,300
-54,300
-50% -$209K ﹤0.01% 857
2019
Q2 		$289K Buy
108,600
+42,300
+64% +$125K ﹤0.01% 976
2019
Q1 		$211K Buy
66,300
+12,000
+22% +$29.5K ﹤0.01% 1032
2018
Q4 		$77K Sell
54,300
-12,000
-18% -$33.9K ﹤0.01% 1099
2018
Q3 		$211K Sell
66,300
-2,000
-3% -$5.96K ﹤0.01% 1054
2018
Q2 		$195K Hold
68,300
– – ﹤0.01% 1050
2018
Q1 		$253K Sell
68,300
-1,500
-2% -$4.91K ﹤0.01% 961
2017
Q4 		$341K Hold
69,800
– – ﹤0.01% 883
2017
Q3 		$341K Hold
69,800
– – ﹤0.01% 889
2017
Q2 		$314K Hold
69,800
– – ﹤0.01% 896
2017
Q1 		$299K Sell
69,800
-6,000
-8% -$24.9K ﹤0.01% 809
2016
Q4 		$309K Buy
75,800
+5,500
+8% +$29.2K ﹤0.01% 753
2016
Q3 		$557K Hold
70,300
– – 0.01% 646
2016
Q2 		$551K Buy
70,300
+11,700
+20% +$100K 0.01% 669
2016
Q1 		$441K Sell
58,600
-11,000
-16% -$80.6K 0.01% 679
2015
Q4 		$749K Buy
69,600
+1,000
+1% +$9.09K 0.01% 614
2015
Q3 		$474K Buy
68,600
+13,000
+23% +$106K 0.01% 704
2015
Q2 		$493K Buy
55,600
+2,000
+4% +$18.9K 0.01% 704
2015
Q1 		$528K Buy
53,600
+1,200
+2% +$15K 0.01% 703
2014
Q4 		$644K Sell
52,400
-4,600
-8% -$56.2K 0.01% 639
2014
Q3 		$569K Sell
57,000
-268,500
-82% -$2.49M 0.01% 630
2014
Q2 		$2.46M Buy
325,500
+266,000
+447% +$1.06M 0.04% 381
2014
Q1 		$196K Buy
59,500
+4,500
+8% +$15.7K ﹤0.01% 721
2013
Q4 		$179K Buy
55,000
+1,000
+2% +$2.9K ﹤0.01% 676
2013
Q3 		$163K Buy
54,000
+1,500
+3% +$10.3K ﹤0.01% 687
2013
Q2 		$433K Buy
+52,500
New +$401K 0.01% 465

Other funds holding ACHN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DekaBank Deutsche Girozentrale's ACHN Position: Q4 2019 in Review

DekaBank Deutsche Girozentrale sold out of Achillion Pharmaceuticals (ACHN) in Q4 2019, closing a stake of 54,300 shares — an estimated $199K sold.

DekaBank Deutsche Girozentrale first reported a position in ACHN in Q2 2013 and held it in 26 quarters. The position peaked at $2.46M in Q2 2014. 132 funds tracked by Wall St. Rank hold ACHN as of Q4 2019.

  • DekaBank Deutsche Girozentrale reported no remaining Achillion Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 54,300 Achillion Pharmaceuticals shares in Q4 2019, an estimated $199K.
  • DekaBank Deutsche Girozentrale first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 26 quarters.
  • DekaBank Deutsche Girozentrale's Achillion Pharmaceuticals position peaked at $2.46M in Q2 2014.
  • 132 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2019.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2019, filed 4 Feb 2020.